Skip to main content
OpenTrials

Clinical trial condition

Advanced Solid Tumor

Explore clinical trials studying Advanced Solid Tumor. Study availability and eligibility vary by location and protocol.

514 public trials 240 recruiting studies
Refine in advanced search Browse all conditions

Advanced Solid Tumor trial results

Completed

A Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Efficacy of TT125-802 in Subjects With Advanced Solid Tumors

NCT06403436

Conditions
Adult Disease, Adult Solid Tumor, Advanced Solid Tumor, +9 more
Locations
  • Sarah Cannon Research Institute Oncology Partners Nashville, Tennessee, United States
  • NEXT Oncology Virginia Fairfax, Virginia, United States
  • NEXT Oncology Barcelona Barcelona, Spain
  • Vall d'Hebron Institute of Oncology Barcelona, Spain
View Trial Details
Completed

BGB-15025 Alone and in Combination With Anti-PD-1 Monoclonal Antibody Tislelizumab in Participants With Advanced Solid Tumors

NCT04649385

Conditions
Advanced Solid Tumor
Locations
  • Icahn School of Medicine At Mount Sinai New York, United States
  • The University of Texas Md Anderson Cancer Center Houston, Texas, United States
  • Ut Health San Antonio Mays Cancer Center San Antonio, Texas, United States
  • Prince of Wales Hospital Randwick, New South Wales, Australia
View all 20 locations
View Trial Details
Completed

Vilastobart (XTX101) Monotherapy and Vilastobart and Atezolizumab Combination Therapy in Advanced Solid Tumors

NCT04896697

Conditions
Advanced Solid Tumor
Locations
  • Mayo Clinic Hospital Phoenix, Arizona, United States
  • City of Hope Duarte, California, United States
  • California Cancer Associates for Research and Excellence, cCARE Encinitas, California, United States
  • City of Hope-Lennar Irvine, California, United States
View all 19 locations
View Trial Details
Completed

BGB-43395 Alone or as Part of Combination Therapies in Chinese Participants With HR+/HER2- Breast Cancer and Other Advanced Solid Tumors

NCT06253195

Conditions
Advanced Solid Tumor, Breast Cancer, Breast Diseases, +14 more
Locations
  • Beijing Cancer Hospital Beijing, Beijing Municipality, China
  • Fujian Cancer Hospital Fuzhou, Fujian, China
  • Sun Yat Sen Memorial Hospital, Sun Yat Sen University (South) Guangzhou, Guangdong, China
  • Guangxi Medical University Cancer Hospital Nanning, Guangxi, China
View Trial Details
Completed

A First-in-Human Study of BGB-C354 Alone and in Combination With Tislelizumab in Participants With Advanced Solid Tumors

NCT06422520

Conditions
Advanced Solid Tumor
Locations
  • Florida Cancer Specialist Research Institute Lake Nona Orlando, Florida, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Washington University School of Medicine St Louis, Missouri, United States
  • The University of Texas Md Anderson Cancer Center Houston, Texas, United States
View all 14 locations
View Trial Details
Completed

XTX202 in Patients With Advanced Solid Tumors

NCT05052268

Conditions
Advanced Solid Tumor
Locations
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • Norris Comprehensive Cancer Center Los Angeles, California, United States
  • University of California Los Angeles Los Angeles, California, United States
  • Hoag Memorial Hospital Presbyterian- Newport Beach Newport Beach, California, United States
View all 15 locations
View Trial Details
Completed

A Phase I/II Study of TJ004309 for Advanced Solid Tumor

NCT04322006

Conditions
Advanced Solid Tumor
Locations
  • The First Affiliated Hospital of Anhui Medical University Hefei, Anhui, China
  • Cancer Hospital, Chinese Academy of Medical Sciences Beijing, Beijing Municipality, China
  • Army Medical Center of PLA Chongqing, Chongqing Municipality, China
  • Chongqing Cancer Hospital Chongqing, Chongqing Municipality, China
View all 23 locations
View Trial Details
Completed

PM14 Administered Intravenously to Patients With Advanced Solid Tumors

NCT05076396

Conditions
Advanced Solid Tumor, Neoplasms
Locations
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • MD Anderson Cancer Center Houston, Texas, United States
  • Gustave Roussy Villejuif, París, France
  • Hospital Universitari Vall d'Hebron Barcelona, Catalonia, Spain
View Trial Details

Related conditions